This educational session aims to improve general practitioners’ confidence and accuracy in identifying patients at risk of lung cancer and understanding the referral and management pathways available through the Patient Pathways Manager and low-dose CT (LDCT) screening programs.
Participants will review clinical risk factors, red flag symptoms, and the role of LDCT scanning in early detection, while exploring how to integrate evidence-based screening into chronic disease management. The session also emphasises multidisciplinary coordination and timely referrals to improve outcomes through early diagnosis and intervention.
By completing this activity, participants will be able to:
-
Recognise the key risk factors and early clinical indicators for potential lung cancer in primary care.
-
Understand the role of low-dose CT scanning in lung cancer screening and early detection.
-
Apply evidence-based patient selection criteria for referral to LDCT or specialist assessment.
-
Navigate the patient pathways for investigation, diagnosis, and multidisciplinary management of suspected lung cancer.
-
Integrate proactive case review and early referral processes into general practice to enhance patient outcomes.
-
Limited GP confidence in identifying early signs and risk factors for lung cancer.
-
Knowledge gaps around low-dose CT (LDCT) eligibility and screening protocols.
-
Uncertainty in navigating referral and diagnostic pathways for suspected lung cancer.
-
Need to improve coordination and communication between primary care and specialist services.
-
Support for data-driven case review and proactive patient follow-up to enable early detection.
-
Gain practical knowledge to support early identification of potential lung cancer patients.
-
Develop competence in ordering and interpreting LDCT results appropriately.
-
Learn to use the Patient Pathways Manager to streamline referrals and follow-up.
-
Enhance collaboration and communication with multidisciplinary teams.
-
Apply updated screening practices to improve patient outcomes through early diagnosis.
AUS
can